Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 24INDUSTRY 4OTHER_GOV 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Breast 3Tumor-Agnostic 1Thoracic 1Other 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Cisplatin 10apatinib 5Surgical Procedures, Operative 4Radiotherapy 4Paclitaxel 4Hyperthermic Intraperitoneal Chemotherapy 4Hydralazine 4Gemcitabine 4Carboplatin 4Valproic Acid 3Neoadjuvant Therapy 3Drug Therapy 3Bevacizumab 3taxane 2pembrolizumab 2cetrorelix 2Radiotherapy, Intensity-Modulated 2Probiotics 2Population Groups 2Poly(ADP-ribose) Polymerase Inhibitors 2Metformin 2Laparoscopy 2Indocyanine Green 2Etoposide 2Curcumin 2CP protocol 2Brachytherapy 2spartalizumab 1piperine 1olaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Standard of Care × Gynecologic × Clear all
NCT04070976 2023-11-14

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer

National Institute of Cancerología

Phase NA Unknown
82 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡